Bg pattern

INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion

Cefazolin

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the package leaflet:

  1. What INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion is and what it is used for
  2. What you need to know before you use INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion
  3. How to use INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion
  4. Possible side effects
  5. Storage of INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion
  6. Contents of the pack and other information

1. What INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion is and what it is used for

This medicinal product belongs to a group of antibiotics called cephalosporins.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold.

It is essential that you follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medicinal product. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste.

INTRAZOLINA 1,000 mg is used to treat the following bacterial infections:

  • Respiratory infections
  • Urinary infections
  • Infections of the skin and soft tissues
  • Infections of the gallbladder and bile ducts
  • Infections of bones and joints
  • Heart infections
  • Infection caused by the passage of bacteria into the blood (septicemia)
  • In the prevention of infections in surgery
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before using INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion

Do not use INTRAZOLINA 1,000 mg

  • If you are allergic (hypersensitive) to cefazolin, other cephalosporins, or any of the other components of INTRAZOLINA 1,000 mg.

Warnings and precautions

  • If you experience intense and prolonged diarrhea, it may be due to a special type of colitis called pseudomembranous colitis, which can be severe. In this case, your doctor will suspend the administration of cefazolin and initiate appropriate treatment.
  • If you undergo prolonged treatment with INTRAZOLINA, other infections (superinfections) may appear due to the overgrowth of some organisms such as Candida.
  • If you have kidney failure, your doctor may need to adjust the dose of cefazolin you receive.
  • If you are going to have a blood test, inform the healthcare staff that you are being treated with this medicinal product, as cefazolin may interfere with the results.

Using INTRAZOLINA with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

INTRAZOLINA must not be administered simultaneously with:

  • Other antibiotics with a similar mechanism of action, such as tetracyclines, sulfonamides, erythromycin, and chloramphenicol
  • Medicines that make the blood more fluid (anticoagulants)
  • Probenecid
  • Medicines toxic to the kidneys

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

In case of pregnancy, your doctor will decide whether to use this medicine.

Ask your doctor or pharmacist for advice before taking any medicine.

In case of breastfeeding, your doctor will decide whether to use this medicine.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Cefazolin generally does not affect the ability to drive vehicles and use machines.

INTRAZOLINA 1,000 mg contains sodium.

Patients on low-sodium diets should note that this medicinal product contains 51 mg (2.22 mmol) of sodium per dose.

3. How to use INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion

Follow exactly the administration instructions for this medicinal product indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

This medicinal product can be administered by intramuscular injection or by slow intravenous injection.

Remember that administration must be carried out by medical personnel.

Remember to request the administration of your medicine.

Your doctor will indicate the appropriate dose and determine the duration of your treatment; do not stop it before finishing or prolong it.

A dose reduction may be necessary if you have any kidney or liver impairment. In such cases, inform your doctor so that they can adjust the dose accordingly.

The recommended dose is:

Adults and adolescents (12 to 18 years):for mild infections, 500 mg every 8 hours; for moderate to severe infections, 500 mg to 1 g every 6 or 8 hours; for more severe infections, 1 to 1.5 g every 6 hours.

Pediatric population (over 1 year and under 12 years) and infants (over 1 month and under 12 months):a total daily dose of 25 to 50 mg per kg of body weight, divided into three or four equal doses, is effective in most mild to moderate infections. The total daily dose should not exceed 100 mg/kg, even in cases of severe infections.

If you use more INTRAZOLINA 1,000 mg than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at telephone 91 562 04 20, indicating the medicine and the amount used.

If you forget to use INTRAZOLINA 1,000 mg

Do not use a double dose to make up for forgotten doses.

If you stop treatment with INTRAZOLINA 1,000 mg

Do not stop treatment before finishing it, as the desired effect will not be achieved. It is very important to treat infections for the recommended time; otherwise, they may worsen.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, INTRAZOLINA 1,000 mg can cause side effects, although not everybody gets them.

The following side effects have been reported according to the frequencies detailed below:

Common: may affect up to 1 in 10 people

Uncommon: may affect up to 1 in 100 people

Rare: may affect up to 1 in 1,000 people

Very rare: may affect up to 1 in 10,000 people

Frequency not known: cannot be estimated from the available data

Infections and infestations:

Genital infections.

Blood and lymphatic system disorders:

Decrease in the number of white blood cells, red blood cells, and platelets.

Immune system disorders:

Most commonly, the appearance of skin lesions that can have a varied appearance. Other possible reactions are itching, swelling of the face, difficulty breathing.

Nervous system disorders:

Dizziness, discomfort, fatigue, difficulty falling asleep, nightmares, weakness, and convulsive crises may occur.

Gastrointestinal disorders:

Nausea, loss of appetite, vomiting, diarrhea, mouth ulcers, and anal itching.

Hepatobiliary disorders:

Transient elevation of some enzymes (transaminases), rarely hepatitis, and yellowing of the skin.

Skin and subcutaneous tissue disorders:

Itching in the genital area.

Renal and urinary disorders:

Increased urea in the blood, which may indicate poor kidney function, rarely kidney inflammation.

General disorders and administration site conditions:

Pain at the injection site and inflammation of the vein at the injection site.

If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.

5. Storage of INTRAZOLINA 1,000 mg powder and solvent for solution for injection and infusion

Keep this medicinal product out of the sight and reach of children.

Store in the original packaging to protect from light.

Do not store above 25°C.

The reconstituted solution with the solvent is stable for 8 hours at a temperature not exceeding 25°C and for 24 hours if stored in the refrigerator (2-8°C).

Do not use INTRAZOLINA 1,000 mg after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicinal products in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicinal products. This will help protect the environment.

6. Contents of the pack and other information

Composition of INTRAZOLINA 1,000 mg

The active substance is cefazolin.

Each vial contains 1,000 mg of cefazolin (as cefazolin sodium). The other components are water for injections.

Appearance and packaging of the product

INTRAZOLINA 1,000 mg is presented as a white or almost white powder, or slightly yellowish, and solvent for solution for injection. It is presented in packs with 1 vial of 1,000 mg of cefazolin powder and 1 ampoule of 4 ml of water for injections as solvent, and clinical packs with 100 vials and 100 ampoules of solvent.

Other presentations

INTRAZOLINA 500 mg powder and solvent for solution for injection and infusion: pack with 1 vial + 1 ampoule of 2 ml of water for injections. Clinical pack with 100 vials + 100 ampoules.

Not all pack sizes may be marketed.

Marketing authorisation holder

LDP-LABORATORIOS TORLAN, S.A.

Ctra. de Barcelona, 135-B

08290 Cerdanyola del Vallès

Barcelona

Manufacturer

LDP-LABORATORIOS TORLAN, S.A.

Ctra. de Barcelona, 135-B

08290 Cerdanyola del Vallès

Barcelona

or

  • BRAUN MEDICAL, S.A.

Huelma, 5. Poligono Industrial Los Olivares. (Jaen) - 23009 - Spain

or

LABORATORIOS INIBSA, S.A

Ctra Sabadell-Granollers, km 14,5. (Llissa de Vall) - 08185 - Spain

Date of last revision of this leaflet:November 2011

-----------------------------------------------------------------------------------------------------------------

Warning: For use exclusively by a healthcare professional

This information is intended only for doctors or healthcare professionals:

  • Stability of the reconstituted INTRAZOLINA solution:

After reconstitution, INTRAZOLINA can be stored for up to 3 hours at a temperature below +25°C and up to 6 hours between +2 and +8°C.

The slightly yellowish color of the solution does not indicate a change in the efficacy of the antibiotic or its tolerance. Solutions with a yellowish-brown or brown color should not be administered.

The stability of the INTRAZOLINA solution at a concentration of 5 mg/ml to 10 mg/ml is satisfactory in the following infusion liquids:

  • Sodium chloride 0.9%
  • Glucose 5% or 10%
  • Glucose 5% in Ringer's lactate
  • Sodium chloride 0.9% and glucose 5%
  • Sodium chloride 0.45% and glucose 5%
  • Ringer's lactate
  • Fructose 5% or 10% in water for injection
  • How to prepare this medicinal product

INTRAZOLINA 1,000 mg will be administered according to the following instructions:

Intravenous administration

Intrazolina can be administered by direct intravenous injection or by continuous or intermittent infusion.

For direct intravenous injection (bolus):

Intravenous injection: 1,000 mg reconstituted and diluted in 10 ml of water for injection. The solution is injected slowly over 3 to 5 minutes (it should not be administered in less than three minutes).

For continuous or intermittent intravenous infusion:

Intrazolina can be administered through the main infusion systems for liquids, controlling the infusion rate, or in a second infusion bag. The reconstitution of 1,000 mg of cefazolin can be performed with its solvent and then diluted in 50 to 100 ml of one of the following intravenous solutions:

  • Sodium chloride 0.9%
  • Glucose 5% or 10%
  • Glucose 5% in Ringer's lactate
  • Sodium chloride 0.9% and glucose 5%
  • Sodium chloride 0.45% and glucose 5%
  • Ringer's lactate
  • Fructose 5% or 10% in water for injection

Intramuscular administration

For intramuscular injection, INTRAZOLINA 1,000 mg is reconstituted with the solvent from the accompanying ampoule (4 ml of water for injections). Shake well until dissolved. Cefazolin should be injected into a area of large muscle mass.

Intramuscular cefazolin causes pain at the injection site.

Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION

Discuss questions about INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION?
INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION?
The active ingredient in INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION is cefazolin. This information helps identify medicines with the same composition but different brand names.
Who manufactures INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION?
INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION is manufactured by Ldp Laboratorios Torlan S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to INTRAZOLINA 1000 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION?
Other medicines with the same active substance (cefazolin) include CEFAZOLIN LDP LABORATORIOS TORLAN 1g POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, CEFAZOLIN LDP LABORATORIOS TORLAN 2g POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, CEFAZOLIN NORMON 1 g POWDER AND SOLVENT FOR INTRAMUSCULAR INJECTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media